hsa-mir-151b: Hsa-mir-151b is an upregulated miRNA that has been identified in various studies [PMC8875566] [PMC8377872] [PMC7880712] [PMC9281551] [PMC7565463] [PMC9353269] [PMC8794677] [PMC7298138] [PMC6959019]. It has been found to be expressed in sEVs from non-pregnant women, suggesting that it is not specific to pregnancy [PMC8377872]. Hsa-mir-151b has also been associated with the risk of developing gestational diabetes mellitus (GDM) later in pregnancy, with a classification efficiency of 100% and 82% for without and with cross-validation, respectively, using a machine learning and LogitBoost algorithm [PMC8377872]. In addition, hsa-mir-151b has been identified as a potential blood biomarker for Alzheimer's disease (AD) and has been found to interact with GPER1 [PMC7565463]. It is also differentially expressed in lymphoma patients before and after therapy, as well as in colorectal cancer carcinoma metastasis and various other diseases or conditions such as ES (Ewing sarcoma), GIST (gastrointestinal stromal tumor), OS (osteosarcoma), SS (synovial sarcoma), and bovine miRNAs studies that have homologous sequences with humans and mice databases.